Xie, Yiyu
Kazakova, Vera
Weeks, Lachelle D.
Gerber, Jonathan M.
Tai, Jesse
Zhang, Tian Y. http://orcid.org/0000-0002-6274-0763
Lowsky, Robert
Wu, Xiaojin http://orcid.org/0000-0003-3894-0631
Yang, Chengwu
Patel, Shyam A. http://orcid.org/0000-0002-8208-1902
Funding for this research was provided by:
UMASS | Center for Clinical and Translational Science, University of Massachusetts (UL1TR001453)
Edward P. Evans Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5K08CA248940-04)
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R01DE029963)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (P50MH129701)
Article History
Received: 4 April 2024
Revised: 13 August 2024
Accepted: 15 August 2024
First Online: 25 August 2024
Competing interests
: SAP served on the Myelodysplastic Syndrome advisory board and the Acute Myeloid Leukemia advisory board for Bristol Myers Squibb and served on the Multiple Myeloma advisory board for Pfizer. LDW reports consulting fees from AbbVie, Vertex and Sobi all unrelated to the present work. JMG served on an MDS Advisory Board for Novartis and holds US Patent No. 9012215, US Patent No. 10222376, and US Patent No. 11209435. Other authors have no conflicts of interest.
: All methods were performed in accordance with the relevant guidelines and regulations. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were strictly followed. Informed consent is not applicable as this was a meta-analysis. There are no patient identifiable images in this manuscript.